Xeris Biopharma Holdings, Inc.

SUSQUEHANNA INTERNATIONAL GROUP, LLP XERS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

117,355

Value ($000)

921

Weight

0.0%

2021 Q4 - 2025 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	921	0.0%	117,355	12/31/2025
2025 Q3	11/14/2025	663	0.0%	81,471	9/30/2025
2025 Q2	8/14/2025	1,897	0.0%	406,202	6/30/2025
2025 Q1	5/14/2025	3,501	0.0%	637,782	3/31/2025
2024 Q4	2/14/2025	364	0.0%	107,344	12/31/2024
2024 Q3	11/14/2024	228	0.0%	79,915	9/30/2024
2024 Q2	8/15/2024	73	0.0%	32,246	6/30/2024
2024 Q1	5/7/2024	61	0.0%	27,390	3/31/2024
2023 Q4	2/14/2024	384	0.0%	163,229	12/31/2023
2023 Q3	11/14/2023	198	0.0%	106,231	9/30/2023
2023 Q2	8/11/2023	324	0.0%	123,672	6/30/2023
2023 Q1	5/16/2023	217	0.0%	133,393	3/31/2023
2022 Q4	2/14/2023	85	0.0%	63,569	12/31/2022
2022 Q3	11/14/2022	149	0.0%	95,787	9/30/2022
2022 Q2	8/15/2022	98	0.0%	63,392	6/30/2022
2022 Q1	5/16/2022	1,083	0.0%	423,176	3/31/2022
2021 Q4	2/14/2022	2,445	0.0%	834,536	12/31/2021